PAVmed Inc (PAVMZ) Stock Analysis

What PAVmed Inc does

PAVmed Inc. functions as a medical technology enterprise based in the United States. Its primary offerings feature CarpX, a patented, single-use, disposable, and minimally invasive surgical tool developed for addressing carpal tunnel syndrome. The company also provides EsoCheck, an esophageal cell collection device facilitating the early identification of esophageal adenocarcinoma and Barrett's Esophagus (BE), along with EsoGuard, an advanced DNA assay utilizing bisulfite-converted next-generation sequencing. Moreover, the firm's developmental pipeline encompasses EsoCure, an esophageal ablation device aimed at treating dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and the Veris cancer care platform. Founded in 2014, the corporation initially operated under the name PAXmed Inc., subsequently adopting its current designation, PAVmed Inc., in April 2015. Its corporate headquarters are located in New York, New York.

Key metrics

ETFs linked to PAVMZ

Broad-market and Healthcare sector ETFs an investor holding PAVmed Inc is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how PAVMZ fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for PAVmed Inc?

PAVmed Inc trades under the ticker PAVMZ on NASDAQ.

Which exchange is PAVMZ listed on?

PAVMZ is listed on NASDAQ.

What sector does PAVmed Inc operate in?

PAVmed Inc is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze PAVMZ in a portfolio?

PortView shows PAVMZ's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.